Pile-O

Quote






HAHAHAHAHAHAHAHAHAHAHA......!!!

Lead the North America Pricing and Market Access Strategies for new product development
-Champion the payer perspective and drive it into brand strategy and implementation
-Ensure appropriate involvement of all NPD team members and leadership in payer-related brand deliverables
-Develop payer communication plans and work with other brand team members and market research companies as they integrate and deliver this through their communication activities
-Communicate project issues and progress effectively and in a timely manner to all stakeholders including European Market Access and marketing teams
Define pricing and market access options for strategic markets for lead indications and that optimize the value of life cycle management opportunities
- Provide a clear commercial evaluation of each strategic option, balancing risks and benefits for the brand
-Deliver credible, commercially viable payer and patient value stories for key payer types in strategic markets that positions HEOR for evidence based strategy
-Provide Pricing and Market Access leadership in emerging and brand teams to ensure all relevant pricing and value issues are integrated into strategies and plans
-Collaborate on the development and specification of the pricing and market access strategy, value story and supporting evidence base
-Develop clear, treatment-focused value propositions and other core global value materials and ensure acceptance by influential markets i.e. U.S., first launch markets
-Ensure local plans and dossiers of influential markets (US, first launch markets, UK, Canada,) are effectively coordinated and that the use of key clinical evidence is consistently applied and interpreted across markets
-Provide any necessary revisions to pricing and market access strategies and value stories that optimize the value of life cycle management opportunities
 
























Anonymous said:
Formulary access has never been a problem, the problem is the generics - their market share is approaching 20% and growing!
Click to expand...

Yet the wholesale price of generic Suboxone is still above Film. I'm sure the generic houses gave some deals to insurance plans, but nothing we couldn't match. RP was in over his head, plain and simple. We can't sell against insurance plans that mandate generics. You can get a few doctors to fight the plans, but most will simply cave bc they don't have the time to spend all day on the phone appealing.
 












Anonymous said:
You just described a formulary access problem, genius.
Click to expand...

Actually, the problem is your have the Brits who have NO IDEA of how commercial managed markets work, with a former MC director who was grossly over-valued and grossly over-relied upon. That combination will always result in poor contract positioning with lost market share.
 












There you go, talking to your imaginary perpetrator again. Of course, you ASSume he or she is not still with the company. Denial. It will never just be a river in Egypt. No, I doubt seriously that the AP sits at a desk. More likely, you describe yourself, a lonely sales rep, driving around in circles, with nothing to do, but post a pissy remark on Café Pharma. Either that, or you are sitting in some obscure coffee shop, mostly mad at yourself for not choosing some other way to make a living. Its all on you and about you. No one else. All your venom is just being deflected onto some imaginary person, who happens to work somewhere else and certainly, not in the field. Oh hell no, because the field is just so full of healthy people, right?
 






Anonymous said:
There you go, talking to your imaginary perpetrator again. Of course, you ASSume he or she is not still with the company. Denial. It will never just be a river in Egypt. No, I doubt seriously that the AP sits at a desk. More likely, you describe yourself, a lonely sales rep, driving around in circles, with nothing to do, but post a pissy remark on Café Pharma. Either that, or you are sitting in some obscure coffee shop, mostly mad at yourself for not choosing some other way to make a living. Its all on you and about you. No one else. All your venom is just being deflected onto some imaginary person, who happens to work somewhere else and certainly, not in the field. Oh hell no, because the field is just so full of healthy people, right?
Click to expand...
Not even going to try and understand how that is relevant to this discussion....
 






Agreed - well that's Rob for you. But his typical approach of attempting to walk others around in circles is no more. He's basically exposed and on hold until they can figure out how to get rid of him. He's pathetic and sits in that corner office like a chimp on display, trying to look like he's relevant. He's the laughing stock of the company.

Karma's a bitch
 






Anonymous said:
Agreed - well that's Rob for you. But his typical approach of attempting to walk others around in circles is no more. He's basically exposed and on hold until they can figure out how to get rid of him. He's pathetic and sits in that corner office like a chimp on display, trying to look like he's relevant. He's the laughing stock of the company.

Karma's a bitch
Click to expand...

Be sure its not YOU that's the laughing stock of this company, because the only thing you are right about is that KARMA IS A REAL BITCH, especially when it blows right back into your face.
 










































Anonymous said:
Agreed - well that's Rob for you. But his typical approach of attempting to walk others around in circles is no more. He's basically exposed and on hold until they can figure out how to get rid of him. He's pathetic and sits in that corner office like a chimp on display, trying to look like he's relevant. He's the laughing stock of the company.

Karma's a bitch
Click to expand...

Ha! perfectly said. He's a joke now for all the company to see.
 






Top Bottom
Back
Quote